Skip to content

Vvus stock split

Vvus stock split

VIVUS Announces 1-for-10 Reverse Stock Split Nasdaq:VVUS Sep 10, 2018 · At the effective time of the reverse stock split, every 10 shares of VIVUS issued and outstanding common stock will automatically be combined and converted into 1 issued and outstanding share of VIVUS, Inc. Common Stock (VVUS) Institutional Holdings ... Find the latest Institutional Holdings data for VIVUS, Inc. Common Stock (VVUS) at Nasdaq.com. Looking for additional market data? Will Tesla Finally Do a Stock Split Now?

Stock split history for VIVUS since 1994. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the …

Find the latest VIVUS, Inc. (VVUS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. View VVUS's stock price, price target, earnings, financials, forecast, insider trades , An investor that had 100 shares of VIVUS stock prior to the reverse split  VIVUS, Inc. Common Stock (VVUS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Find the latest VIVUS, Inc. (VVUS) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

VBI Vaccines (VBIV) has 1 split in our VBIV split history database. The split for VBIV took place on July 29, 2014. This was a 1 for 5 reverse split, meaning for each 5 shares of VBIV owned pre-split, the shareholder now owned 1 share. VVUS VIVUS, Inc. Stock Quote - FINVIZ.com VIVUS, Inc. operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater …

VIVUS, Inc. operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater …

It was JNUG and it reverse split 1:5 last night. On the upside we had two winners with Vivus (VVUS) introducing a remote monitoring platform for use when  Akers Biosciences (AKER) Stock Is Up On COVID-19 Vaccine Update VIVUS ( VVUS) Stock Is Gaining In Multiples On Social Distance Product. Read breaking biotech stock news from BioSpace, the Home of the Life Sciences VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, 

Vivus stock rallies above $5 mark in volatile trade after ...

Stockholders approved the reverse stock split at the 2018 Annual Meeting of Stockholders on September 7, 2018, and on the same day, VIVUS’ Board of Directors approved the implementation of the reverse stock split and the ratio of 1-for-10. Shares of VIVUS common stock will trade on a post-split basis beginning on September 11, 2018. The Reason For Today’s -16.48% Weakness in VIVUS, Inc ...

Apex Business WordPress Theme | Designed by Crafthemes